COVID-19: Indonesia to provide vaccines to 9.1 million people at 1st phase

Published On 2020-10-20 04:30 GMT   |   Update On 2020-10-20 05:41 GMT

Jakarta: Indonesia will at the first phase provide the Covid-19 vaccine to 9.1 million people between November and December 2020, the Health Ministry's Disease Control and Prevention Director General Achmad Yurianto said.The first phase of vaccination will be carried out on the groups of people with highest risk of Covid-19 infections, namely medical and public service workers including...

Login or Register to read the full article

Jakarta: Indonesia will at the first phase provide the Covid-19 vaccine to 9.1 million people between November and December 2020, the Health Ministry's Disease Control and Prevention Director General Achmad Yurianto said.

The first phase of vaccination will be carried out on the groups of people with highest risk of Covid-19 infections, namely medical and public service workers including airport employees, soldiers and police personnel, Xinhua news agency reported on Monday.
Yurianto said that the vaccine would only be given to people aged between 18 years old and 59 years old, because clinical trials of vaccine candidates in the world have yet to target categories outside that age range.
The vaccination will be carried out after the Indonesian Drug and Food Supervisory Agency (BPOM) issues an emergency use authorization and the Indonesian Ulema Council (MUI) provides halal certification.


Tags:    
Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News